Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor

Gastroenterology

Volumn 136, Issue 5, 2009, Pages 1721-1731

  Elinav, Eran ^a   Adam, Nitzan ^a   Waks, Tova ^a   Eshhar, Zelig ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PICRIC ACID; RECOMBINANT RECEPTOR; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR FOXP3; TRIPARTITE CHIMERIC RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL BASED GENE THERAPY; CELL EXPANSION; COLITIS; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GENETIC ENGINEERING; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

EID: 65249120858     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.01.049     Document Type: Article

References (46)

1. Chen W., Jin W., and Wahl S.M. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4(+) T cells. J Exp Med 188 (1998) 1849-1857
2. Hsieh C.S., Zheng Y., Liang Y., et al. An intersection between the self-reactive regulatory and nonregulatory T-cell receptor repertoires. Nat Immunol 7 (2006) 401-410
3. Tanchot C., Vasseur F., Pontoux C., et al. Immune regulation by self-reactive T cells is antigen specific. J Immunol 172 (2004) 4285-4291
4. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2 (2002) 389-400
5. Asano M., Toda M., Sakaguchi N., et al. Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation. J Exp Med 184 (1996) 387-396
6. Maul J., Loddenkemper C., Mundt P., et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128 (2005) 1868-1878
7. Mottet C., Uhlig H.H., and Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170 (2003) 3939-3943
8. Hori S., Haury M., Coutinho A., et al. Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T-cell receptor transgenic mice. Proc Natl Acad Sci U S A 99 (2002) 8213-8218
9. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
10. Masteller E.L., Tang Q., and Bluestone J.A. Antigen-specific regulatory T cells-ex vivo expansion and therapeutic potential. Semin Immunol 18 (2006) 103-110
11. Mekala D.J., Alli R.S., and Geiger T.L. IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc Natl Acad Sci U S A 102 (2005) 11817-11822
12. Elinav E., Waks T., and Eshhar Z. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. Gastroenterology 134 (2008) 2014-2024
13. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
14. Li L., Godfrey W.R., Porter S.B., et al. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 106 (2005) 3068-3073
15. Friedmann-Morvinski D., Bendavid A., Waks T., et al. Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation. Blood 105 (2005) 3087-3093
16. Eshhar Z., Waks T., Gross G., et al. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ξ subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci U S A 90 (1993) 720-724
17. Becker C., Fantini M.C., Wirtz S., et al. In vivo imaging of colitis and colon cancer development in mice using high-resolution chromoendoscopy. Gut 54 (2005) 950-954
18. Pinthus J.H., Waks T., Malina V., et al. Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes. J Clin Invest 114 (2004) 1774-1781
19. Pandiyan P., Zheng L., Ishihara S., et al. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 8 (2007) 1353-1362
20. Erhardt A., Biburger M., Papadopoulos T., et al. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in Concanavalin A-induced liver injury in mice. Hepatology 45 (2007) 475-485
21. Hombach A.A., Kofler D., Hombach A., et al. Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2. J Immunol 179 (2007) 7924-7931
22. Kim S.J., and Diamond B. Generation and maturation of bone marrow-derived DCs under serum-free conditions. J Immunol Methods 323 (2007) 101-108
23. Malek T.R., Yu A., Zhu L., et al. IL-2 family of cytokines in T regulatory cell development and homeostasis. J Clin Immunol 28 (2008) 635-639
24. Moriggl R., Topham D.J., Teglund S., et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10 (1999) 249-259
25. Banz A., Pontoux C., and Papiernik M. Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J Immunol 169 (2002) 750-757
26. Weber S.E., Harbertson J., Godebu E., et al. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J Immunol 176 (2006) 4730-4739
27. Huang C.T., Workman C.J., Flies D., et al. Role of LAG-3 in regulatory T cells. Immunity 21 (2004) 503-513
28. Gondek D.C., Lu L.F., Quezada S.A., et al. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 174 (2005) 1783-1786
29. Watanabe T., Yoshida M., Shirai Y., et al. Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver. J Immunol 168 (2002) 2188-2199
30. Askenasy N., Yolcu E.S., Yaniv I., et al. Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood 105 (2005) 1396-1404
31. Thornton A.M., and Shevach E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 164 (2000) 183-190
32. Piccirillo C.A., and Shevach E.M. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 167 (2001) 1137-1140
33. Sarween N., Chodos A., Raykundalia C., et al. CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J Immunol 173 (2004) 2942-2951
34. Kuniyasu Y., Takahashi T., Itoh M., et al. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T-cell subpopulation. Int Immunol 12 (2000) 1145-1155
35. Duthoit C.T., Mekala D.J., Alli R.S., et al. Uncoupling of IL-2 signaling from cell cycle progression in naive CD4+ T cells by regulatory CD4+CD25+ T lymphocytes. J Immunol 174 (2005) 155-163
36. Inaba H., and Geiger T.L. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T lymphocytes. Int Immunol 18 (2006) 1043-1054
37. Collison L.W., Workman C.J., Kuo T.T., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 (2007) 566-569
38. Miyara M., and Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13 (2007) 108-116
39. Gavin M.A., Rasmussen J.P., Fontenot J.D., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
40. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T-cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
41. Kim J.Y., Kim H.J., Hurt E.M., et al. Functional and genomic analyses of FOXP3-transduced Jurkat-T cells as regulatory T (Treg)-like cells. Biochem Biophys Res Commun 362 (2007) 44-50
42. Allan S.E., Broady R., Gregori S., et al. CD4+ T-regulatory cells: toward therapy for human diseases. Immunol Rev 223 (2008) 391-421
43. Brusko T.M., Putnam A.L., and Bluestone J.A. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 223 (2008) 371-390
44. Elpek K.G., Yolcu E.S., Franke D.D., et al. Ex vivo expansion of CD4+CD25+FoxP3+ T-regulatory cells based on synergy between IL-2 and 4-1BB signaling. J Immunol 179 (2007) 7295-7304
45. Montcuquet N., Mercier-Letondal P., Perruche S., et al. Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells. Immunology 125 (2008) 320-330
46. Kang S.M., Tang Q., and Bluestone J.A. CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects. Am J Transplant 7 (2007) 1457-1463